title: Dynamic Regulation of AMPAR Phosphorylation In Vivo Following Acute Behavioral Stress.
abstract: The tuning of glutamatergic transmission is an essential mechanism for neuronal communication. α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) are ionotropic glutamate receptors that mediate fast synaptic transmission. The phosphorylation states of specific serine residues on the GluA1 and GluA2 AMPAR subunits are considered critical post-translational modifications that regulate AMPAR activity and subcellular trafficking. While behavioral stress, via stress hormones, exerts specific alterations on such glutamatergic processes, there have been conflicting data concerning the influence of stress on AMPAR phosphorylation in different brain regions, and the post-stress signaling mechanisms mediating these processes are not well delineated. Here, we examined the dynamics of phosphorylation at three AMPAR serine residues (ser831-GluA1, ser845-GluA1, and ser880-GluA2) in four brain regions [amygdala, medial prefrontal cortex (mPFC), dorsal hippocampus, and ventral hippocampus] of the rat during the hour following behavioral stress. We also tested the impact of post-stress corticosteroid receptor blockade on AMPAR phosphorylation. Both GluA1 subunit residues exhibited elevated phosphorylation after stress, yet post-stress administration of corticosteroid receptor antagonists curtailed these effects only at ser831-GluA1. In contrast, ser880-GluA2 displayed a time-dependent tendency for early decreased phosphorylation (that was selectively augmented by mifepristone treatment in the amygdala and mPFC of stressed animals) followed by increased phosphorylation later on. These findings show that the in vivo regulation of AMPAR phosphorylation after stress is a dynamic and subunit-specific process, and they provide support for the hypothesis that corticosteroid receptors have an ongoing role in the regulation of ser831-GluA1 phosphorylation during the post-stress interval.
authors.affiliation: Physiopathologie des Maladies Psychiatriques, UMR_S 894 Inserm, Centre de Psychiatrie et Neurosciences, 2ter rue d'Alesia, 75014, Paris, France.|Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
authors.forename: Dorian
authors.initials: D
authors.lastname: Caudal
authors.affiliation: Physiopathologie des Maladies Psychiatriques, UMR_S 894 Inserm, Centre de Psychiatrie et Neurosciences, 2ter rue d'Alesia, 75014, Paris, France.
authors.forename: Marion
authors.initials: M
authors.lastname: Rame
authors.affiliation: Physiopathologie des Maladies Psychiatriques, UMR_S 894 Inserm, Centre de Psychiatrie et Neurosciences, 2ter rue d'Alesia, 75014, Paris, France.|Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
authors.forename: Thérèse M
authors.initials: TM
authors.lastname: Jay
authors.affiliation: Physiopathologie des Maladies Psychiatriques, UMR_S 894 Inserm, Centre de Psychiatrie et Neurosciences, 2ter rue d'Alesia, 75014, Paris, France. bp.godsil@gmail.com.|Université Paris Descartes, Sorbonne Paris Cité, Paris, France. bp.godsil@gmail.com.
authors.forename: Bill P
authors.initials: BP
authors.lastname: Godsil
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism; D003345:Corticosterone / Q000097:blood; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology; D010766:Phosphorylation; D051381:Rats; D017207:Rats, Sprague-Dawley; D018091:Receptors, AMPA / Q000378:metabolism*; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors; D012694:Serine / Q000378:metabolism; D013315:Stress, Psychological / Q000378:metabolism*
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D018091:Receptors, AMPA; D011965:Receptors, Glucocorticoid; D012694:Serine; D003345:Corticosterone
keywords: AMPA; Amygdala; Phosphorylation; Prefrontal cortex; Spironolactone; Stress
references.citation: J Neurosci. 2007 Dec 19;27(51):14171-8
references.pmid: 18094256
references.citation: PLoS One. 2012;7(6):e40020
references.pmid: 22768202
references.citation: J Neurosci. 2009 Nov 11;29(45):14299-308
references.pmid: 19906977
references.citation: Neuroscience. 2009 Jan 12;158(1):105-25
references.pmid: 18424006
references.citation: Neurosci Lett. 1993 May 14;154(1-2):73-7
references.pmid: 8103203
references.citation: J Neurochem. 2009 Jun;109(6):1733-44
references.pmid: 19383086
references.citation: Nat Neurosci. 2008 Aug;11(8):868-70
references.pmid: 18622402
references.citation: Exp Neurol. 2008 Jun;211(2):593-6
references.pmid: 18436212
references.citation: Biol Psychiatry. 2006 Nov 15;60(10):1147-54
references.pmid: 16806107
references.citation: Front Neuroendocrinol. 2003 Jul;24(3):151-80
references.pmid: 14596810
references.citation: Front Behav Neurosci. 2014 Jan 29;8:19
references.pmid: 24523684
references.citation: J Neurochem. 2009 Jan;108(1):147-57
references.pmid: 19046328
references.citation: Neuropsychopharmacology. 2010 Feb;35(3):674-85
references.pmid: 19890264
references.citation: Nat Rev Neurosci. 2007 Feb;8(2):101-13
references.pmid: 17237803
references.citation: Stress. 2015 Jan;18(1):96-106
references.pmid: 25472821
references.citation: Am J Psychiatry. 2004 Aug;161(8):1370-6
references.pmid: 15285961
references.citation: Neuropsychopharmacology. 2011 Aug;36(9):1848-58
references.pmid: 21544067
references.citation: Depress Anxiety. 2009;26(8):718-23
references.pmid: 19496077
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:240-5
references.pmid: 22889863
references.citation: Nat Methods. 2014 Jun;11(6):629-32
references.pmid: 24776635
references.citation: Biol Psychiatry. 2008 Oct 15;64(8):708-717
references.pmid: 18635156
references.citation: J Endocrinol. 2011 May;209(2):153-67
references.pmid: 21357682
references.citation: PLoS One. 2010 Dec 08;5(12):e15282
references.pmid: 21170339
references.citation: Nat Rev Neurosci. 2005 Jun;6(6):463-75
references.pmid: 15891777
references.citation: Physiol Behav. 1980 Nov;25(5):753-8
references.pmid: 7443837
references.citation: J Neurophysiol. 2010 Jan;103(1):479-89
references.pmid: 19906877
references.citation: Addict Biol. 2015 Jan;20(1):158-69
references.pmid: 24102978
references.citation: J Neurosci. 2003 Oct 8;23(27):9220-8
references.pmid: 14534256
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19204-7
references.pmid: 16361444
references.citation: Neuropsychopharmacology. 2012 Dec;37(13):2870-80
references.pmid: 22948976
references.citation: Science. 2003 Jun 13;300(5626):1751-5
references.pmid: 12805550
references.citation: Mol Cell Neurosci. 2011 Jan;46(1):1-8
references.pmid: 20817097
references.citation: Science. 2004 Oct 29;306(5697):882-4
references.pmid: 15514161
references.citation: J Neurosci Methods. 1980 Dec;3(2):129-49
references.pmid: 6110810
references.citation: Neurosci Biobehav Rev. 2009 Jun;33(6):773-83
references.pmid: 19111570
references.citation: Learn Mem. 2012 Jun 20;19(7):300-6
references.pmid: 22723052
references.citation: J Comp Neurol. 2000 Oct 16;426(2):243-58
references.pmid: 10982466
references.citation: J Neurochem. 1994 Sep;63(3):1095-103
references.pmid: 8051550
references.citation: Nat Neurosci. 2011 Jun;14(6):727-35
references.pmid: 21516102
references.citation: Nat Rev Neurosci. 2008 May;9(5):387
references.pmid: 18401345
references.citation: Annu Rev Cell Dev Biol. 2007;23:613-43
references.pmid: 17506699
references.citation: Endocrinology. 1985 Dec;117(6):2505-11
references.pmid: 2998738
references.citation: J Neurophysiol. 2005 Dec;94(6):3951-60
references.pmid: 16107533
references.citation: J Neurosci. 2009 Sep 9;29(36):11203-14
references.pmid: 19741127
references.citation: J Consult Clin Psychol. 2000 Oct;68(5):748-66
references.pmid: 11068961
references.citation: Neuropharmacology. 2005 Jun;48(7):936-48
references.pmid: 15857620
references.citation: Schizophr Bull. 2003;29(4):671-92
references.pmid: 14989406
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14075-9
references.pmid: 19666502
references.citation: Hippocampus. 2011 Sep;21(9):1028-35
references.pmid: 20572199
references.citation: Nature. 2000 Jun 22;405(6789):955-9
references.pmid: 10879537
references.citation: CNS Spectr. 2009 Jan;14(1 Suppl 1):44-51
references.pmid: 19169193
references.citation: J Neuroendocrinol. 2000 Oct;12(10):1034-42
references.pmid: 11012846
references.citation: Pharmacol Rev. 2012 Oct;64(4):901-38
references.pmid: 23023031
references.citation: Brain. 2013 Dec;136(Pt 12):3753-65
references.pmid: 24271563
references.citation: J Neurosci. 2007 Nov 28;27(48):13210-21
references.pmid: 18045915
references.citation: Nat Rev Neurosci. 2011 Nov 30;13(1):22-37
references.pmid: 22127301
references.citation: Mol Psychiatry. 2011 Feb;16(2):156-70
references.pmid: 20458323
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3269-74
references.pmid: 10077673
references.citation: J Neurosci. 2000 Oct 1;20(19):7258-67
references.pmid: 11007883
references.citation: Cell. 2007 Oct 5;131(1):160-73
references.pmid: 17923095
references.citation: J Biol Chem. 2006 Jan 13;281(2):752-8
references.pmid: 16272153
references.citation: J Neuroendocrinol. 2010 Aug;22(8):846-61
references.pmid: 20367759
references.citation: J Biol Chem. 2014 May 23;289(21):14600-11
references.pmid: 24706758
references.citation: J Psychopharmacol. 2012 Apr;26(4):516-24
references.pmid: 21965192
references.citation: Neuropharmacology. 2009 Jan;56(1):37-46
references.pmid: 18657555
references.citation: Annu Rev Med. 1997;48:231-40
references.pmid: 9046958
references.citation: Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14449-54
references.pmid: 20663957
references.citation: Physiol Rev. 2007 Jul;87(3):873-904
references.pmid: 17615391
references.citation: J Neurosci. 2004 Dec 8;24(49):11029-34
references.pmid: 15590919
references.citation: Mol Psychiatry. 2013 Apr;18(4):471-84
references.pmid: 22733125
references.citation: Learn Behav. 2004 Aug;32(3):299-310
references.pmid: 15672825
references.citation: Steroids. 2008 Oct;73(9-10):885-8
references.pmid: 18329060
references.citation: Cereb Cortex. 2010 Oct;20(10):2433-41
references.pmid: 20080931
references.citation: Expert Opin Investig Drugs. 2012 Sep;21(9):1323-50
references.pmid: 22834476
references.citation: Eur J Neurosci. 2008 Jun;27(12):3284-91
references.pmid: 18598267
references.citation: Cereb Cortex. 2004 Feb;14(2):224-9
references.pmid: 14704220